Podcasts about international aids conference

This podcast outlines some of the data presented at the 25th International AIDS Conference from HPTN 084 as it pertains to using injectable cabotegravir for HIV PrEP during pregnancy. Related Content:  https://www.hptn.org/research/studies/hptn-084 https://programme.aids2024.org/Programme/Session/349 CEI toll free line for NYS providers: 866-637-2342 https://ceitraining.org/

When the fight against HIV meets the resilience of Indigenous communities, advocacy becomes a lifeline. Trevor Stratton, a member of the Mississaugas of the Credit First Nation, shares his journey from diagnosis to becoming a powerful voice in the Indigenous HIV community. As the International AIDS Conference looms, Trevor dives into the pressing need for culturally safe education and messaging to combat stigma and discrimination. He sheds light on the importance of being "undetectable" and the unique epidemiological challenges faced by Indigenous populations. His story is a testament to the power of trust, community, and advocacy in breaking down the barriers to healthcare access.Catch the full video version of this episode on YouTubeFollow Sickboy on Instagram, TikTok and Discord!

When the fight against HIV meets the resilience of Indigenous communities, advocacy becomes a lifeline. Trevor Stratton, a member of the Mississaugas of the Credit First Nation, shares his journey from diagnosis to becoming a powerful voice in the Indigenous HIV community. As the International AIDS Conference looms, Trevor dives into the pressing need for culturally safe education and messaging to combat stigma and discrimination. He sheds light on the importance of being "undetectable" and the unique epidemiological challenges faced by Indigenous populations. His story is a testament to the power of trust, community, and advocacy in breaking down the barriers to healthcare access.Catch the full video version of this episode on YouTubeFollow Sickboy on Instagram, TikTok and Discord!

The HIV Science as Art exhibition brought twelve artists with HIV together with scientists to create original work that reflects the concepts of their scientific work at the International AIDS Conference 2024 in Munich, Germany. These works represented a diverse spectrum of artistic expression – from fashion design and painting to photography, sculpture and video. All originals were then auctioned off with the proceeds being used to support programs and services for people living with HIV. In this episode we'll hear from scientists, artists and curators about their work and their experiences. Check out our other JOY Podcasts for more on LGBTIQ+ health and wellbeing at joy.org.au/wellwellwell. If there's something you'd like us to explore on the show, send through ideas or questions at wellwellwell@joy.org.au Find out more about LGBTIQ+ services and events in Victoria at thorneharbour.org and in South Australia at samesh.org.au.

This week on “The Top Line,” we discuss two studies in HIV research that were presented at the 25th International AIDS Conference in Germany. One of them is the report of a 7th person who has likely been cured of HIV. And there's something unique about this case that has sparked excitement among scientists. The other one is the report of a long-acting injection that showed 100% efficacy in preventing HIV infection in a phase 3 trial. Some experts have hailed the PrEP candidate as a game-changer. To dive deeper into these studies, Fierce Pharma's Angus Liu interviews Jared Baeten, M.D., Ph.D., senior vice president and head of clinical development of the virology therapeutic area at Gilead Sciences.  To learn more about the topics in this episode:  With seventh person seemingly cured of HIV, signs of hope for a broader cure  Watch out, GSK. Gilead's twice-yearly PrEP drug shows 100% efficacy for HIV prevention  See omnystudio.com/listener for privacy information.

This week Jess shares further news and insight from the International AIDS Conference 2024 - including the huge leaps forward with Lenacapavir, hailed as "the closest we have ever been to an HIV vaccine", a game-changer for STI prevention with DoxyPrEP and Hans Berlin the pornstar! We have learnt so much, a huge thank you to everyone involved in such an incredible event!Sources HIV drug could be made for just $40 a year for every patient | Global development | The GuardianAIDS 2024, the 25th International AIDS Conference | AIDS 2024 | International AIDS Society (IAS) (iasociety.org)Get Involved With Our Podcast!Say our intro!It's that simple. All you need to do is send us a voice note of you saying "Welcome to The HIV Podcast" and send it to us! We'll read out who you are and anything else you'd like us to add. You can also put a little flare onto you intro - we love being surprised!Suggest a topicIf there is something, someone you think The HIV Podcast should consider covering, let us know!You can do this via Whatsapp, DM or email or even just leave us a note in the comments on social media!Email: office@tvps.org.ukWhatsapp: 07727666791Or find us on Instagram and Tiktok @TheHIVPodcast Hosted on Acast. See acast.com/privacy for more information.

Advances in HIV research often unfold rapidly. In order to deliver state-of-the-art care, healthcare providers who manage this patient population must stay abreast of data emerging from the major conferences.These educational podcasts will spotlight the latest advances in the treatment and prevention of HIV and related comorbidities with a series of ‘what you need to know' videos from data presented during the 25th International AIDS Conference.Launch Date: August 1, 2024Release Date: August 1, 2024Expiration Date: July 31, 2025FACULTYPaul Sax, MDClinical DirectorDivision of Infectious DiseasesBrigham and Women's HospitalProfessor of MedicineHarvard Medical SchoolThis podcast provides accredited continuing education credits.  To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.https://www.practicepointcme.com/CMEHome/clinical-clips174-spotlighting-hot-topics-in-hiv-independent-coverage-from-the-25th-international-aids-conference-aids-2024-1

Advances in HIV research often unfold rapidly. In order to deliver state-of-the-art care, healthcare providers who manage this patient population must stay abreast of data emerging from the major conferences.These educational podcasts will spotlight the latest advances in the treatment and prevention of HIV and related comorbidities with a series of ‘what you need to know' videos from data presented during the 25th International AIDS Conference.Launch Date: August 1, 2024Release Date: August 1, 2024Expiration Date: July 31, 2025FACULTYPaul Sax, MDClinical DirectorDivision of Infectious DiseasesBrigham and Women's HospitalProfessor of MedicineHarvard Medical SchoolThis podcast provides accredited continuing education credits.  To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.https://www.practicepointcme.com/CMEHome/clinical-clips174-spotlighting-hot-topics-in-hiv-independent-coverage-from-the-25th-international-aids-conference-aids-2024-1

Advances in HIV research often unfold rapidly. In order to deliver state-of-the-art care, healthcare providers who manage this patient population must stay abreast of data emerging from the major conferences.These educational podcasts will spotlight the latest advances in the treatment and prevention of HIV and related comorbidities with a series of ‘what you need to know' videos from data presented during the 25th International AIDS Conference.Launch Date: August 1, 2024Release Date: August 1, 2024Expiration Date: July 31, 2025FACULTYPaul Sax, MDClinical DirectorDivision of Infectious DiseasesBrigham and Women's HospitalProfessor of MedicineHarvard Medical SchoolThis podcast provides accredited continuing education credits.  To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.https://www.practicepointcme.com/CMEHome/clinical-clips174-spotlighting-hot-topics-in-hiv-independent-coverage-from-the-25th-international-aids-conference-aids-2024-1

Advances in HIV research often unfold rapidly. In order to deliver state-of-the-art care, healthcare providers who manage this patient population must stay abreast of data emerging from the major conferences.These educational podcasts will spotlight the latest advances in the treatment and prevention of HIV and related comorbidities with a series of ‘what you need to know' videos from data presented during the 25th International AIDS Conference.Launch Date: August 1, 2024Release Date: August 1, 2024Expiration Date: July 31, 2025FACULTYPaul Sax, MDClinical DirectorDivision of Infectious DiseasesBrigham and Women's HospitalProfessor of MedicineHarvard Medical SchoolThis podcast provides accredited continuing education credits.  To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.https://www.practicepointcme.com/CMEHome/clinical-clips174-spotlighting-hot-topics-in-hiv-independent-coverage-from-the-25th-international-aids-conference-aids-2024-1

From the 2024 International AIDS Conference in Munich, Germany, Cal brings us stories from the AIDS Global Village including: Louisa from northern Germany speaking about their work in reaching vulnerable populations offering counselling and testing via their mobile testing van Yianny from Tackle HIV which educates young people on HIV, and sexual health and reproductive rights using football as a point of connection Kai and Chi-Wei from Taiwan speaking about HIVStory Professor David Gere from the University of California speaking about his work as Co-Director of Through Positive Eyes Maggie Czarnogorski, the Head of Digital Innovation and Implementation Science at ViiV Healthcare speaks about a virtual reality experience aiming to better educate people on the stigma and discrimination that people living with HIV face Check out our other JOY Podcasts for more on LGBTIQ+ health & wellbeing. If there's something you'd like us to explore on the show, send through ideas or questions at wellwellwell@joy.org.au Find out more about LGBTIQ+ services and events in Victoria at Thorne Harbour Health and in South Australia at SAMESH.

Bongani Bingwa chats with Mia Malan, Editor-In-Chief of Bhekisisa, about the important topics covered at this year's AIDS 2024 Conference in Munich, including the approved injection that provides 100% HIV protection and the use of 95-95-95 data to determine resource allocation.See omnystudio.com/listener for privacy information.

This week Sarah and Jess have been virtually attending the 25th annual International AIDS Conference and in the first of two special episodes, they bring you some highlights from the conference! Hosted on Acast. See acast.com/privacy for more information.

Jack and Cal discuss the International AIDS Conference 2024 in Munich, Germany, and hear from: IAS President Dr Sharon Lewin giving an overview of the landscape HIV exists within today Executive Director of UN AIDS Winnie Byanyima speaking to the progress around the global respond to HIV, including a significant increase from 47% of PLHIV in treatment 9 years ago, to 77% on treatment today Andriy Klepikov, AIDS 2024 Regional Co-Chair & Ukranian Advocate discussing the hybrid war being waged in the region including on the LGBTIQ+ people, drug users, TGD communities and science more broadly Jay Mulucha, Fem Alliance Uganda Executive Director discussing the harsh realities of people a trans man living with HIV in Uganda in the shadow of their recent Anti-Homosexuality Laws enacted earlier this year as the first trans man to speak at the opening ceremonies of an International AIDS Conference Dr Christian Gaebler giving a summary about the 7th person effectively cured of HIV Dr Troy Grennan from the British Colombia Center for Disease Control looking at the efficacy of 100mg daily for the prevention of STIs, and ‘Maria' Groot Bruinderink from Public Health Service Amsterdam on PrEP for HIV Prevention with less frequent monitoring to help reduce the burden of frequency of doctors visits from every 3 months to every 6 months Check out our other JOY Podcasts for more on LGBTIQ+ health & wellbeing. If there's something you'd like us to explore on the show, send through ideas or questions at wellwellwell@joy.org.au Find out more about LGBTIQ+ services and events in Victoria at Thorne Harbour Health and in South Australia at SAMESH.

This episode of HIV unmuted introduces a new host and format for the award-winning IAS podcast. Our host, Juan Michael Porter II, the Senior Editor for TheBody/TheBodyPro, takes a deep dive with a single guest in an intimate conversation that gives the listener a glimpse of the guest – who they are and how they got into this work – and an understanding of their topic of expertise.   This new format opens with Sharon Lewin, the IAS President and AIDS 2024 International Co-Chair, walking us through the latest HIV science released at AIDS 2024, the 25th International AIDS Conference, and what it means for the HIV response. This episode delves into a broad range of exciting science, from long-acting injectables to new research on doxycycline prophylaxis to advances in cure research, including inspiration from the “next Berlin Patient”.  Through the lens of her personal story, Sharon walks us through the context and challenges of the HIV response, such as changing global health priorities and reduced funding for HIV. Astounding progress has been made in the HIV response. Yet, we are still missing critical targets. Sharon makes it clear that if we are to envision the end of the HIV pandemic, we must address persisting inequalities that remain in the HIV response: we must put people first. Meet our guest Sharon LewinThe IAS President and AIDS 2024 International Co-Chair, Sharon Lewin, is an infectious diseases physician and basic scientist and has worked in HIV-related clinical medicine and research for over 25 years. She is Director of the Peter Doherty Institute for Infection and Immunity, a joint venture of the University of Melbourne and Royal Melbourne Hospital in Melbourne, Australia. The Doherty Institute has over 850 staff working on infection and immunity through research, education and public health, and has a significant focus on virology, including HIV. She is an active clinician, working at the Alfred Hospital and Royal Melbourne Hospital, and a Melbourne Laureate Professor of Medicine at the University of Melbourne.    Meet our host Juan Michael Porter II Juan Michael Porter II is a health journalist, HIV advocate, culture critic, educator and the host of HIV unmuted, the IAS podcast. He is the Senior Editor of TheBody.com and TheBodyPro – and the first person openly living with HIV to hold the position. Juan Michael's reportage combines data dives, personal narratives and policy analyses to address the real-world consequences of ever-shifting legislation on people's health outcomes. He has written for the Public Broadcasting Service, SF Chronicle, Philadelphia Inquirer, Christian Science Monitor, NY Observer, TDF Stages, Playbill, American Theatre, Time Out NY, Queerty, Anti-Racism Daily, Positively Aware, Documentary Magazine, SYFY Wire, Scholastic and Dance Magazine.  

U.S. President Joe Biden has officially ended his bid for re-election - endorsing Vice President Kamala Harris as the new Democratic nominee. The decision comes after weeks of intense criticism about his age and mental stamina - and is shaking up the presidential race, less than four months before election day. Also: Hot and dry conditions across much of Western Canada are making wildfires worse - creating poor air quality and forcing hundreds to evacuate their homes. Plus: The International AIDS conference begins in Munich next week - and researchers are already sharing details on the development of a new stem cell treatment for the disease.

This podcast features Dr Ishwar Gilada who had established India's first AIDS clinic in 1986 when first HIV case had got diagnosed in the country. Dr Gilada is the longest serving HIV medical expert in India, President-Emeritus of AIDS Society of India, part of Governing Council of IAS (International AIDS Society) and 25th International AIDS Conference organising committee. He is in conversation with CNS Founder and Managing Editor Shobha Shukla.Listen to this podcast on Apple Podcasts, Amazon Music, Spotify, YouTube Music, TuneIn, Podtail, BluBrry, Himalaya, ListenNotes, American Podcasts, CastBox FM, Ivy FM, Player FM, iVoox, and other podcast streaming platforms.ThanksCNS team

This week we talk about HIV, AIDS, and ART.We also discuss HAART, the Berlin Patient, and potential future cures.Recommended Book: Allergic by Theresa MacPhailShow Notes* https://www.unaids.org/en/resources/fact-sheet* https://hivinfo.nih.gov/understanding-hiv/fact-sheets/hiv-treatment-basics* https://clinicalinfo.hiv.gov/en/glossary/antiretroviral-therapy-art* https://www.paho.org/en/topics/antiretroviral-therapy* https://journals.lww.com/jaids/fulltext/2010/01010/declines_in_mortality_rates_and_changes_in_causes.13.aspx* https://link.springer.com/article/10.1007/s13181-013-0325-8* https://academic.oup.com/jac/article/73/11/3148/5055837?login=false* https://journals.lww.com/jaids/fulltext/2016/09010/narrowing_the_gap_in_life_expectancy_between.6.aspx* https://en.wikipedia.org/wiki/Tenofovir_disoproxil* https://en.wikipedia.org/wiki/Management_of_HIV/AIDS* https://www.verywellhealth.com/cart-hiv-combination-antiretroviral-therapy-48921* https://www.cdc.gov/hiv/risk/art/index.html* https://www.freethink.com/health/cured-of-hiv* https://www.jstor.org/stable/3397566?origin=crossref* https://www.nytimes.com/1982/05/11/science/new-homosexual-disorder-worries-health-officials.html* https://pubmed.ncbi.nlm.nih.gov/23444290/* https://my.clevelandclinic.org/health/diseases/4251-hiv-aids* https://web.archive.org/web/20080527201701/http://data.unaids.org/pub/EPISlides/2007/2007_epiupdate_en.pdf* https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(23)00028-0/fulltextTranscriptIn mid-May of 1981, the queer community-focused newspaper, the New York Native, published what would become the first-ever article on a strange disease that seemed to be afflicting community members in the city.What eventually became known as AIDS, but which was at the time discussed by medical professionals primarily in terms of its associated diseases, was clinically reported upon for the first time less than a month later, five official cases having been documented in an interconnected group of gay men and users of injectable drugs, who came to the attention of doctors for not being inherently immunocompromised, but still somehow contracting a rare type of pneumonia that only really impacted folks with severely impaired immune systems.In subsequent years, doctors started using a range of different terms for HIV and AIDS, calling them at different times and in different contexts the lymphotophic retrovirus, Kaposi's sarcoma and opportunistic infections, and the 4H disease, referring to heroine users, hemophiliacs, homosexuals, and Haitians, the four groups that seemed to make up almost all of the confirmed afflicted patients.The acronym GRID, for gay-related immune deficiency was also used for a time, but that one was fairly rapidly phased out when it became clear that this condition wasn't limited to the gay community—though those earlier assumptions and the terminology associated with them did manage to lock that bias into mainstream conversation and understanding of AIDS and HIV for a long time, and in some cases and in some locations, to this day.By the mid-80s, two research groups had identified different viruses that seemed to be associated with or responsible for cases of this mysterious condition, and it was eventually determined (in 1986) that they were actually the same virus, and that virus was designated HIV.HIV, short for Human Immunodeficiency Virus, is a retrovirus that, if left untreated, leads to Acquired Immunodeficiency Syndrome, or AIDS, in about 50% of patients within ten years of infection.So HIV is the virus, AIDS is a condition someone with HIV can develop after their immune system is severely damaged by the infection, and there are a bunch of diagnostic differentiations that determine when someone has transitioned from one category to the other, but in general folks with HIV will experience moderate flu- or mono-like symptoms, alongside swollen lymph nodes and rashes and throat problems and sores across their bodies in the early stages of infection, and as things progress, they develop opportunistic infections of the kind that can only really latch onto a human when their immune system is weakened or shut down. While AIDS, arriving after the immune system is well and truly damaged, brings with it a slew of opportunistic infections and associated issues, the afflicted person potentially developing all sorts of cancers, sarcomas, persistent infections, and extreme versions of the flu-like, mono-like symptoms they may have suffered earlier on.We don't know for certain how and where HIV originated—and that's true of both kinds, as there's an HIV-1 and HIV-2 virus, the former of which accounts for most infections, the latter of which is less common, and less overall infectious—but both HIV types seem to have been transmitted to humans from non-human primates somewhere in West-central Africa in the early 20th century, possibly from chimpanzees in southern Cameroon, but that's pretty speculative, and there's some evidence that these diseases may have made the leap several times; so while there's a pretty good chance, based on what we know now, that the disease made it into humans and mutated approximately somewhere in that vicinity, sometime in the early 20th century, possibly via chimps hunted and eaten by locals as bushmeat, we really don't know for certain.There are reports of what were probably HIV as far back as 1959 in the Belgian Congo, but that's a bit speculative, too, and based on imperfect notes from the time.Back then, though, and through the 1980s, folks who contracted HIV and who were not treated would typically die within 11 years of being infected, and more than half of those diagnosed with AIDS in the US from 1981 through 1992 died within 2 years of their diagnosis; such a diagnosis was a death sentence, basically; it was a really horrible and scary time.Today, the outlook for folks who contract HIV is substantially better: the life expectancy of someone who contracts the virus and who is able to get treatment is about the same as someone who is not infected; the disease isn't cured, but the level of HIV virus in the blood of a person receiving treatment is so small that it's no longer transmissible, or even detectable.What I'd like to talk about today is a new therapy that's making those sorts of outcomes possible, how some few people have now been cured of HIV entirely, and what's on the horizon in this space.—Antiretroviral therapy, or ART, typically consists of a combination of drugs based on those that were originally combined in this way in 1996 by researchers who announced their findings at the International AIDS Conference in Vancouver—they called their approach highly active antiretroviral therapy, or HAART, and this combo was based on findings from earlier drugs that addressed one of HIV's seven stages of development—but because they all hit that same, single stage, the virus was rapidly developing an immunity to them, and they were universally pretty toxic, with horrible side-effects.What's more, this drug cocktail increased patients' life expectancy by about 24 months, on average—which is a lot, about two years, but considering all those side effects, which included severe liver problems and anemia, the extra months of life generally weren't very pleasant extra months.In 1995, a class of drugs called protease inhibitors were introduced, which prevented HIV from making copies of itself using the body's structural proteins.That, combined with the effects of other, existing retrovirals, which hindered the virus's ability to hijack the body's cells to make more of itself, turned out to be a substantial improvement over just one or the other approach.The announcement in 1996 was notable because the researchers involved were able to knock the viral load in their patients down to an undetectable level, and then keep it there, by using three drugs from each of those two antiviral classes, those two different approaches.So HAART was a major improvement over what came before, but it was still imperfect; deaths tied to HIV plummeted by 50% in the US and Europe in just three years, but the life expectancy of folks using this therapy was still low compared to other people; someone who contracted HIV in their 20s and went on this therapy was still only expected to live till their early 50s; way better than a two-year increase, but still plenty of room for improvement.In addition to that lifespan duration limitation, the HAART bundle of therapies was just really difficult to maintain.Some people experienced a dramatic redistribution of body fat, some developed heart arrhythmias or insulin resistance or peripheral neuropathy or lactic acidosis—which is basically a toxic buildup of the acid that results from metabolism, which is usually cleared naturally, but when it doesn't, it's potentially deadly.Anything less than absolutely perfect adherence to the treatment schedule was also potentially deleterious to the desired outcomes; it wasn't a forgiving regimen, with some of the drugs requiring three capsules be taken every 8 hours, and there was a chance that if a portion of a dose of one drug was missed, or not administered on time, the virus could develop an immunity to it and the whole thing would fall apart.Consequently, the HAART regimen was generally reserved until things got really bad, and that meant it didn't have a very large effect on the infected population, and those who did benefit from it suffered consequences, alongside those benefits.The change in terminology from HAART to ART arrived in 2001 when a drug called Viread, the brand name for tenofovir disoproxil, was released and added into the mix, replacing some of the most toxic and cumbersome of the previous therapies with a single pill per day, and one that came with far fewer, and far less extreme, side effects.In 2005 it was finally demonstrable, with a bunch of data, that beginning this type of therapy early rather than waiting until things get really bad was worth the trade-offs—researchers showed that if folks received access to ART upon diagnosis, severe HIV associated and non HIV associated illnesses  were reduced by 61%.As of 2016 there was still an average life expectancy gap between folks with HIV who received early care and people who were not infected of about 8 years, but that gap has been steadily closing with the introduction of new, easier to use, less side effect prone drugs—drugs that tend to attack the virus at different stages, and which take different approaches to hindering and blocking it—alongside innovations in how the drugs are delivered, like introducing substances that are converted by the body into the desired drug, which massively cuts the requisite dosage, in turn lessening the strain on the body's organs and the potential side effects associated with taking a higher dose of the drug, itself.We've also seen the advent of fixed-dose combination drugs, which are exactly what they sound like: a single pill containing the entire combination of drugs one must take each day, which makes a combination therapy much easier to administration and stick with, which in turn has substantially reduced the risk of severe side effects, and prevented mutations that might otherwise make a patient's virus more immune to some component of the drug cocktail.Some newer options just use two drugs, too, compared to the previous three-or-more, and most of these have been shown to be just as effective as the earlier, more bodily stressful combinations, and a recent, 2021 drug is injectable, rather than deliverable in pill-form, and can be administered just once a month—though a version of this drug, sold under the name Cabenuva, has been approved for administration every other month.So things in this corner of the medical world are looking pretty good, due new approaches and innovations to existing therapy models.These models remain imperfect, but they're getting better every year, and contracting HIV is no longer a death sentence, nor does it mean you'll always be infectious, or even detectably infected: the amount of HIV virus in one's blood can be kept undetectably low for essentially one's entire life, so long as one is able to get on the right therapy or combination of therapies and stick with it.That said, the global HIV pandemic is far from over, and access to these drugs–many of which are pricy, if you don't have insurance that will cover them—is not equally distributed.As of late-2022, the UN's official numbers indicate that about 39 million people, globally, have HIV, about 1.3 million were infected in 2022, and about 630,000 died from AIDS-related illnesses that year.That said, of those 39 million or so who are infected, nearly 30 million are receiving some kind of antiretroviral therapy, and about 86% of people who are estimated to be infected know their status, so they can seek such therapies, and/or take other precautious to protect themselves and others; though that also means about 5.5 million people, globally, have HIV and don't realize it.Here's a really remarkable figure, though: among people who are infected and know they are infected, about 93% of them were virally suppressed as of 2022.That's astonishing; 93% of people who have HIV and are aware of it are on some kind of therapy that has allowed them to suppress the virus so that it's nearly undetectable—the difference between the two, by the way, is that suppressed means 200 copies of the HIV virus per milliliter of blood, while undetectable is generally considered to be less than 50 copies per milliliter.So huge leaps in a relatively short period of time, and a massive improvement in both duration and quality of life for folks who might otherwise suffer mightily, and then die early, because of this virus and its associated symptoms.That said, there are some interesting, new approaches to dealing with HIV on the horizon, and some of them might prove to be even more impactful than this current batch of incredibly impactful ART options.As of September 2023, five people have been confirmed cured of HIV; not suppressed and not with viral loads at undetectable levels: cured.The first of these cured people, often referred to as the Berlin Patient, received a stem cell transplant from a bone marrow donation database that contained a genetic mutation called CCR5 Delta 32, which makes those who have it essentially immune to HIV infection.Three months after he received the transplant and stopped taking ART, doctors were unable to find any trace of the virus in his blood.He died from cancer in 2020, but there didn't seem to be any HIV in his blood from when he received the stem cell transplant, onward, and that happened in the early 2000s, and was formally announced to the medical community in 2008.At least two other people—two that we know about, anyway—have been cured of HIV using the same method; though at the moment at least, this option is severely limited as it requires that patients have a bone marrow match in donor databases, and that one of those donors have that specific, relatively rare mutation; so with existing science and techniques, at least, this is unlikely to be a widespread solution to this problem—though a 2017 experiment used stem cells derived from umbilical cord blood from a baby with that mutation to treat a woman' leukemia and cure her HIV, so there's a chance other approaches that make use of the same basic concept might be developed, opening this up to more people.Cancer drugs may also help some people with HIV: a drug that's been approved to treat several cancers called Venetoclax seems to also bind to a protein that helps HIV-infected T cells dodge the body's immune system and survive, and that realization has led to a series of experiments that showed HIV was suppressed in mice receiving this drug—though it bounced back a week later, and two weeks later in mice receiving both this drug and ART.This is unlikely to be a solution unto itself, then, but there's a chance either an adjusted version of this drug, or this drug in combination with other therapies, might be effective; and there's a clinical trial testing the efficacy of Venetoclax in human HIV patients at the end of this year, and another in 2024, so we may soon know if its safe and desirable to use this drug alongside ART, and that may, in turn, lead to a better understanding of how to amplify the drug's effects, or apply this method of hindering HIV from a different angle.CRISPR, the gene-editing technology borrowed from bacteria that allows for the cutting and removing and adding of genetic information, has enabled the development of several new potential HIV cures, one of which, called EBT-101, basically enters the body, finds helper T cells, and then cuts out chunks of the HIV virus's DNA, which prevents it from being able to replicate itself or hide away, reemerging later after another treatment has suppressed it.The benefit of this approach is that it could kill the viral reservoirs that otherwise allow HIV to persist in people who have undergone treatments, and a version of it that targets SIV, which is similar to HIV, but found in non-human primates—performed exactly as they hoped it would, finding and editing the targeted DNA, raising hopes than an HIV-targeting variation may manage similar wonders in human patients.This would be great if it ends up working, as one injection would theoretically clear all HIV from a person's system in relatively short-order, but the trials done so far have been small and on monkeys, and because of the nature of the research, it's not clear the monkeys were cured of HIV—just that the treatment got where it was supposed to go and made some DNA edits.A human trial of EBT-101 will finish up in March of 2025, though the researchers plan to follow up with their subjects for up to 15 years following the trial, to assess any long-term effects from their treatment, since CRISPR and this approach to messing with genes is still such a new thing.So while this may be a solution at some point, there's a good chance it won't be a real-deal, available option for another decade, minimum.So we've come a long way in a very short period of time with HIV and AIDS treatments, and the future is looking pretty good, with even more options and approaches on the horizon, including some actual cures, alongside high-quality, actually useable treatments.But there's still room to grow in terms of infection awareness, there are still distribution issues for some of these drugs, and there's still a fair bit of prejudice, the consequence of ignorance and historical misunderstandings and biases, keeping folks and institutions from doing as much as they otherwise could in many parts of the world; so a lot to be proud of, a lot to look forward to, but still plenty of room for improvement across the board. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit letsknowthings.substack.com/subscribe

A 12ª Conferência Internacional de Aids (AIDS 2023), da International AIDS Society (IAS), aconteceu entre os dias 23 e 26 de julho, em Brisbane, Austrália. O evento é um dos mais relevantes da área de infectologia e saúde pública do mundo, trazendo estudos, novidades e discussões relevantes a respeito do combate ao HIV. Os assuntos abordados tiveram foco em pesquisas sobre HIV e suas aplicações.      Aperte o play! Confira esse e outros posts no Portal PEBMED e siga nossas redes sociais! Facebook Instagram Linkedin Twitter

In this crossover episode with Pandemic Planet, recorded during the International AIDS Conference in Montreal, Canada, on July 30th, Jeff Sturchio speaks with Dr. Mark Feinberg, president and CEO of the International AIDS Vaccine Initiative (IAVI).  In this interview, Dr. Feinberg addresses the continued progress in HIV prevention and treatment seen in recent years and outlines the challenges still faced in translating this progress into meaningful impact on the lives of people affected by HIV/AIDs. Turning the tide against HIV will require a decline in new infections, which highlights the need for an effective HIV vaccine. Dr. Feinberg discusses the exciting and fascinating progress being made in research on broadly neutralizing antibodies and how the lessons learned from failed vaccine efficacy trials have informed new approaches that have considerable promise for enhancing understanding of how to design effective HIV vaccines. He also explains clearly and compellingly some of the basic biology that makes HIV such a wily and difficult adversary due to its genetic diversity compared to such other pathogens as Ebola and SARS-COV-2. New tools in such areas as mRNA delivery and computational biology are being brought to bear in the search for an HIV vaccine. Dr. Feinberg concludes by expressing his hope that the scientific challenges of HIV will continue to attract the next generation of creative young scientists.  Mark Feinberg leads a global team at IAVI working to advance the development of vaccines and other biomedical innovations to protect against infection with HIV, TB, and other infectious diseases that have a disproportionate impact on low-income countries. Prior to joining IAVI in late 2015, Feinberg served as chief public health and science officer with Merck Vaccines. Dr. Feinberg holds an M.D. and a Ph.D. from Stanford University, and a B.A. degree from the University of Pennsylvania.

In this crossover episode with AIDS' Existential Moment, recorded during the International AIDS Conference in Montreal, Canada, on July 30th, Jeff Sturchio speaks with Dr. Mark Feinberg, president and CEO of the International AIDS Vaccine Initiative (IAVI). In this interview, Dr. Feinberg addresses the continued progress in HIV prevention and treatment seen in recent years and outlines the challenges still faced in translating this progress into meaningful impact on the lives of people affected by HIV/AIDs. Turning the tide against HIV will require a decline in new infections, which highlights the need for an effective HIV vaccine. Dr. Feinberg discusses the exciting and fascinating progress being made in research on broadly neutralizing antibodies and how the lessons learned from failed vaccine efficacy trials have informed new approaches that have considerable promise for enhancing understanding of how to design effective HIV vaccines. He also explains clearly and compellingly some of the basic biology that makes HIV such a wily and difficult adversary due to its genetic diversity compared to such other pathogens as Ebola and SARS-COV-2. New tools in such areas as mRNA delivery and computational biology are being brought to bear in the search for an HIV vaccine. Dr. Feinberg concludes by expressing his hope that the scientific challenges of HIV will continue to attract the next generation of creative young scientists. Mark Feinberg leads a global team at IAVI working to advance the development of vaccines and other biomedical innovations to protect against infection with HIV, TB, and other infectious diseases that have a disproportionate impact on low-income countries. Prior to joining IAVI in late 2015, Feinberg served as chief public health and science officer with Merck Vaccines. Dr. Feinberg holds an M.D. and a Ph.D. from Stanford University, and a B.A. degree from the University of Pennsylvania.

In this podcast, Jennifer Sherwood, PhD, and Elise Lankiewicz, MPH, speak about the current state of trans inclusion in national HIV strategic plans (NSPs) globally, the results from the recent systematic review documenting the quality of transgender inclusion in the NSPs of 60 countries, and how national HIV planning processes can increase trans inclusion. They also spoke about these topics at the International AIDS Conference 2022 during a presentation titled “Systematic Review of Trans Inclusion in National HIV Strategic Plans."

In this crossover episode with Pandemic Planet, recorded during the International AIDS Conference in Montreal, Canada, on July 30th, Jeff Sturchio speaks with Solange Baptiste, Executive Director of the International Treatment Preparedness Coalition (ITPC). This is one in a series of podcasts in which we explore what needs to be done to end the AIDS pandemic, both globally and domestically.     In this wide-ranging interview, Ms. Baptiste addresses the issues that are still creating barriers to equitable access to HIV treatment around the world. She contrasts the excitement at new developments like long-acting prevention tools with the persistent challenge of inequities in HIV care and treatment, especially in middle-income countries. She speaks eloquently of access as a human right and the importance of educating and empowering affected communities to take the lead in creating new solutions. Ms. Baptiste makes a strong case that the world won't achieve access for all unless we tackle structural barriers and power imbalances – and redesign systems to address the needs of people living with or at risk of HIV infection.      Solange Baptiste assumed her current role as Executive Director of ITPC in 2016. She leads community activists and allies across the globe to deliver ITPC's mission to enable people in need to gain access to optimal and affordable HIV treatment through treatment education, demand creation, community-based monitoring, and interventions to make medicines more affordable. She earned her Bachelor of Science in Biology from Tuskegee University and her Master of Science in Population and International Health from the Harvard School of Public Health. Solange is committed to ensuring that the voice of affected communities contributes to and influences the decisions and policies that affect their lives.

Known as “the Barcelona patient”, a 75 year-old-woman who has been off antiretrovirals for 15 years made headlines worldwide this summer when her case was presented at the 24th International AIDS Conference in Montreal, Canada. Alejandra Angulo Alonso is joined by Cristina Tomàs White and Gerard Escaich Folch to talk about the extraordinary Barcelona patient as well as HIV research in Catalonia. We also speak with Dr. Josep Mallolas, the head of Hospital Clínic's HIV-AIDS unit and a member of the research team behind this unique case that could eventually lead to a functional cure for others too. This week's Catalan phrase is ‘No tirar la tovallola', which means “Not giving up.”

In this crossover episode with AIDS' Existential Moment, recorded during the International AIDS Conference in Montreal, Canada, on July 30th, Jeff Sturchio speaks with Solange Baptiste, Executive Director of the International Treatment Preparedness Coalition (ITPC). This is one in a series of podcasts in which we explore what needs to be done to end the AIDS pandemic, both globally and domestically.     In this wide-ranging interview, Ms. Baptiste addresses the issues that are still creating barriers to equitable access to HIV treatment around the world. She contrasts the excitement at new developments like long-acting prevention tools with the persistent challenge of inequities in HIV care and treatment, especially in middle-income countries. She speaks eloquently of access as a human right and the importance of educating and empowering affected communities to take the lead in creating new solutions. Ms. Baptiste makes a strong case that the world won't achieve access for all unless we tackle structural barriers and power imbalances – and redesign systems to address the needs of people living with or at risk of HIV infection.      Solange Baptiste assumed her current role as Executive Director of ITPC in 2016. She leads community activists and allies across the globe to deliver ITPC's mission to enable people in need to gain access to optimal and affordable HIV treatment through treatment education, demand creation, community-based monitoring, and interventions to make medicines more affordable. She earned her Bachelor of Science in Biology from Tuskegee University and her Master of Science in Population and International Health from the Harvard School of Public Health. Solange is committed to ensuring that the voice of affected communities contributes to and influences the decisions and policies that affect their lives.

In this podcast, Davina Canagasabey, with PATH, speaks about delivering responsive, person-centered HIV and primary health care. She also spoke about this topic during her presentation at the International AIDS Conference 2022 titled “Real world impact of integrated person-centered HIV primary health care: better uptake, retention, and health outcomes across 4 countries.”

In this crossover episode with Pandemic Planet, recorded during the International AIDS Conference in Montreal, Katherine speaks with Phelister Abdalla, of KESWA, the Kenya Sex Work Association, and Ruth Morgan Thomas, of the Global Network of Sex Work Projects (NSPW), about the intersection of sex work, HIV/AIDS, and the Covid-19 pandemic. Phelister and Ruth argue that sex workers' livelihoods have been uniquely disrupted by recurring curfews and lockdowns, noting that this often-stigmatized community has not benefitted from the social protection programs many countries established to support workers in the formal sector from loss of jobs or income during the early phases of the pandemic. They highlight how sex workers have instead been at the forefront of community-led initiatives that deliver antiretroviral medications, food, and other essential health commodities to each other, and consider how the integration of HIV/AIDS response into pandemic preparedness and response may affect sex workers and the community people living with HIV. Over the years and across many international AIDS conferences, sex workers have fought for their experiences to be taken into account and for their voices to be heard within the meetings' focus on policy and research agendas. Phelister Abdalla is the National Coordinator of the Kenya Sex Workers Alliance (KESWA) and the President of the Global Network of Sex Work Projects (NSPW), based in Nairobi. She is a single mother of three, and an active sex worker living with HIV for the last 11 years. Ruth Morgan Thomas is the Global Coordinator, Global Network of Sex Work Projects (NSPW). She has been involved in the sex industry for more than 30 years, including as a sex worker, an academic researcher at Edinburgh University, and a sex workers' rights advocate.

In this crossover episode with AIDS' Existential Moment, recorded during the International AIDS Conference in Montreal, Katherine speaks with Phelister Abdalla, of KESWA, the Kenya Sex Work Association, and Ruth Morgan Thomas, of the Global Network of Sex Work Projects (NSPW), about the intersection of sex work, HIV/AIDS, and the Covid-19 pandemic. Phelister and Ruth argue that sex workers' livelihoods have been uniquely disrupted by recurring curfews and lockdowns, noting that this often-stigmatized community has not benefitted from the social protection programs many countries established to support workers in the formal sector from loss of jobs or income during the early phases of the pandemic. They highlight how sex workers have instead been at the forefront of community-led initiatives that deliver antiretroviral medications, food, and other essential health commodities to each other, and consider how the integration of HIV/AIDS response into pandemic preparedness and response may affect sex workers and the community people living with HIV. Over the years and across many international AIDS conferences, sex workers have fought for their experiences to be taken into account and for their voices to be heard within the meetings' focus on policy and research agendas. Phelister Abdalla is the National Coordinator of the Kenya Sex Workers Alliance (KESWA) and the President of the Global Network of Sex Work Projects (NSPW), based in Nairobi. She is a single mother of three, and an active sex worker living with HIV for the last 11 years. Ruth Morgan Thomas is the Global Coordinator, Global Network of Sex Work Projects (NSPW). She has been involved in the sex industry for more than 30 years, including as a sex worker, an academic researcher at Edinburgh University, and a sex workers' rights advocate.

In this crossover episode with Pandemic Planet, recorded during the International AIDS Conference in Montreal, Canada, on July 31st, Jeff Sturchio speaks with Professor Alan Whiteside, Centre for International Governance Innovation Chair emeritus in Global Health Policy at the Balsillie School of International Affairs.     Professor Whiteside begins with a discussion of new treatments and prevention tools for HIV/AIDS that offer the opportunity for those who have access to enjoy longer and healthier lives. But there are still barriers and challenges related to the social determinants of health that lead to persistent inequalities and make it difficult for some population groups (especially African women) to benefit. He calls for a focus on the “real issues that real people face” and for understanding the ways that power relationships and marginalization affect the health of people living with and at risk of HIV infection. He also discusses the interactions of the HIV and Covid-19 epidemics in recent years and the additional strains this has placed on health systems and the economics of the global HIV response. Professor Whiteside concludes with observations on the need for leadership and the power of communities in fashioning sustained responses to the impact of HIV/AIDS.     Born in Kenya but raised in Swaziland (now Eswatini), Alan Whiteside is an internationally recognized academic and AIDS researcher. He was the founding executive director of the Health Economics and HIV/AIDS Research Division at the University of KwaZulu-Natal and is also professor emeritus in the Wilfrid Laurier University School of International Policy and Governance in Waterloo, Ontario and editor-in-chief of the African Journal of AIDS Research. His most recent book is HIV & AIDS: A Very Short Introduction, second edition (Oxford University Press 2016).

In this crossover episode with AIDS' Existential Moment, recorded during the International AIDS Conference in Montreal, Canada, on July 31st, Jeff Sturchio speaks with Professor Alan Whiteside, Centre for International Governance Innovation Chair emeritus in Global Health Policy at the Balsillie School of International Affairs.     Professor Whiteside begins with a discussion of new treatments and prevention tools for HIV/AIDS that offer the opportunity for those who have access to enjoy longer and healthier lives. But there are still barriers and challenges related to the social determinants of health that lead to persistent inequalities and make it difficult for some population groups (especially African women) to benefit. He calls for a focus on the “real issues that real people face” and for understanding the ways that power relationships and marginalization affect the health of people living with and at risk of HIV infection. He also discusses the interactions of the HIV and Covid-19 epidemics in recent years and the additional strains this has placed on health systems and the economics of the global HIV response. Professor Whiteside concludes with observations on the need for leadership and the power of communities in fashioning sustained responses to the impact of HIV/AIDS.     Born in Kenya but raised in Swaziland (now Eswatini), Alan Whiteside is an internationally recognized academic and AIDS researcher. He was the founding executive director of the Health Economics and HIV/AIDS Research Division at the University of KwaZulu-Natal and is also professor emeritus in the Wilfrid Laurier University School of International Policy and Governance in Waterloo, Ontario and editor-in-chief of the African Journal of AIDS Research. His most recent book is HIV & AIDS: A Very Short Introduction, second edition (Oxford University Press 2016).

Join us this week for part two of our two-part coverage of this year's International AIDS Conference. Marianna chats with John Faragon about the latest studies to come out about HIV treatment, two-drug regimens, and more.  --Help us track the number of listeners our episode gets by filling out this brief form!  (https://www.e2NECA.org/?r=WIQ3929)

In this crossover episode with Pandemic Planet, recorded during the International AIDS Conference in Montreal, Katherine speaks with Dr. Adeeba Kamarulzaman, immediate past president of IAS and the International Co-Chair of AIDS 2022, about the themes of this year's conference, “Re-engage and follow the science.” Four years since the last International AIDS Conference took place in Amsterdam, Adeeba discusses the importance of bringing the HIV research, advocacy, and policy communities back together in a hybrid in person/virtual setting to rejuvenate the fight to end the AIDS pandemic. Katherine and Adeeba discuss the exciting new scientific breakthroughs announced at the conference, technical innovations during Covid-19 that that can be successfully applied to HIV programs, and the uncertain future of funding for global HIV/AIDS activities in a period when conflict, food insecurity, climate change, and pandemic preparedness efforts require increased financial investments, as well.    Dr. Adeeba Kamarulzaman is former Dean of the Faculty of Medicine and Professor of Medicine and Infectious Diseases at the University of Malaya in Kuala Lumpur, Malaysia.  

In this crossover episode with AIDS' Existential Moment, recorded during the International AIDS Conference in Montreal, Katherine speaks with Dr. Adeeba Kamarulzaman, immediate past president of IAS and the International Co-Chair of AIDS 2022, about the themes of this year's conference, “Re-engage and follow the science.” Four years since the last International AIDS Conference took place in Amsterdam, Adeeba discusses the importance of bringing the HIV research, advocacy, and policy communities back together in a hybrid in person/virtual setting to rejuvenate the fight to end the AIDS pandemic. Katherine and Adeeba discuss the exciting new scientific breakthroughs announced at the conference, technical innovations during Covid-19 that that can be successfully applied to HIV programs, and the uncertain future of funding for global HIV/AIDS activities in a period when conflict, food insecurity, climate change, and pandemic preparedness efforts require increased financial investments, as well.    Dr. Adeeba Kamarulzaman is former Dean of the Faculty of Medicine and Professor of Medicine and Infectious Diseases at the University of Malaya in Kuala Lumpur, Malaysia.  

This week, we're sitting down with John Faragon to go over everything that went down during this year's International AIDS Conference. Learn all about the PrEP studies covered, the latest on HIV treatment, and more. --Help us track the number of listeners our episode gets by filling out this brief form!  (https://www.e2NECA.org/?r=YYT3918)

In war-torn eastern Ukraine, a non-governmental organisation called the Alliance for Public Health is working to ensure that the fight against HIV and AIDS doesn't fall by the wayside amid the ongoing humanitarian crisis. APH was recently awarded the Elizabeth Taylor Human Rights Award at the 2022 International AIDS Conference in Montreal, for their exceptional courage in their efforts to advocate for human rights in the field of HIV. Executive Director of APH Andrey Klepikov dials in from Ukraine to share more about how members of the Alliance are trying to reach the most vulnerable communities, be it in mobile vans, on bicycle, or on foot.Image credit: Twitter / @AndriyKlepikov

In war-torn eastern Ukraine, a non-governmental organisation called the Alliance for Public Health is working to ensure that the fight against HIV and AIDS doesn't fall by the wayside amid the ongoing humanitarian crisis. APH was recently awarded the Elizabeth Taylor Human Rights Award at the 2022 International AIDS Conference in Montreal, for their exceptional courage in their efforts to advocate for human rights in the field of HIV. Executive Director of APH Andrey Klepikov dials in from Ukraine to share more about how members of the Alliance are trying to reach the most vulnerable communities, be it in mobile vans, on bicycle, or on foot.Image credit: Twitter / @AndriyKlepikov

Cal speaks with Jane Bruning about Sperm Positive at the International AIDS Conference. Sperm Positive started as a public relations campaign to promoting U=U in New Zealand. The message promoted that men living with HIV can have babies through a donor process. Find out more about Sperm Positive at https://spermpositive.com/ Check out our other JOY Podcasts for more on HIV, COVID-19 and queer health & wellbeing. If there's something you'd like us to explore on the show, send through ideas or questions at wellwellwell@joy.org.au

In this crossover episode with Pandemic Planet, recorded during the International AIDS Conference in Montreal, Canada, on July 31st, Jeff Sturchio speaks with Dr. Michel Kazatchkine, Professor of Medicine at the Universite Rene Descartes in Paris, Special Advisor to UNAIDS for Eastern Europe and Central Asia, and a Senior Fellow with the Global Health Centre of the Graduate Institute of International and Development Studies in Geneva.  Professor Kazatachkine reviews the interactions of structural determinants of health, stigma and discrimination, and punitive laws that affect people living with HIV and at-risk populations throughout Eastern Europe and Central Asia. He also discusses the remarkable resilience of people in Ukraine in response to the Russian invasion and outlines the health impacts of reconstruction both in Ukraine and among migrant and refugee populations in surrounding countries. Professor Kazatchkine reminds us that health and human rights involve political choices – and also offer political opportunities. If we hope to achieve an end to AIDS as a public health problem by 2030, we need to work with key populations and communities to deliver solutions that they need. Finally, Jeff and Michel discuss the prospects for long-term financing of the HIV response. We need to think differently about how to sustain programs in a multipolar world, particularly to address the needs of middle-income countries.    Professor Michel Kazatchkine has dedicated more than 30 years to fighting AIDS and promoting global health as a physician, research, advocate,policmake, diplomat, and administrator. Among his many other roles, he has directed the French National Ressearch Agency (ANRS), the world's second largest AIDS research programs; served as France's global ambassador for HIV/AID and transmissible diseases; led the Global Fund to Fight AIDS, TB, and Malaria; and served as the UN Secretary General's Special Envoy on HIV/AIDS in Eastern Europe and Central Asia.  

In this crossover episode with AIDS' Existential Moment, recorded during the International AIDS Conference in Montreal, Canada, on July 31st, Jeff Sturchio speaks with Dr. Michel Kazatchkine, Professor of Medicine at the Universite Rene Descartes in Paris, Special Advisor to UNAIDS for Eastern Europe and Central Asia, and a Senior Fellow with the Global Health Centre of the Graduate Institute of International and Development Studies in Geneva. Professor Kazatachkine reviews the interactions of structural determinants of health, stigma and discrimination, and punitive laws that affect people living with HIV and at-risk populations throughout Eastern Europe and Central Asia. He also discusses the remarkable resilience of people in Ukraine in response to the Russian invasion and outlines the health impacts of reconstruction both in Ukraine and among migrant and refugee populations in surrounding countries. Professor Kazatchkine reminds us that health and human rights involve political choices – and also offer political opportunities. If we hope to achieve an end to AIDS as a public health problem by 2030, we need to work with key populations and communities to deliver solutions that they need. Finally, Jeff and Michel discuss the prospects for long-term financing of the HIV response. We need to think differently about how to sustain programs in a multipolar world, particularly to address the needs of middle-income countries. Professor Michel Kazatchkine has dedicated more than 30 years to fighting AIDS and promoting global health as a physician, research, advocate, policy maker, diplomat, and administrator. Among his many other roles, he has directed the French National Research Agency (ANRS), the world's second largest AIDS research programs; served as France's global ambassador for HIV/AID and transmissible diseases; led the Global Fund to Fight AIDS, TB, and Malaria; and served as the UN Secretary General's Special Envoy on HIV/AIDS in Eastern Europe and Central Asia.

CORE TOPICS + DETAILS:[0:10] - Monkeypox Outbreak ContinuesNational health emergency declaredEven though experts don't expect monkeypox to be the next COVID, it has swiftly become a déjà vu nightmare. Last week, President Biden declared a health emergency for monkeypox. This announcement came weeks after many major cities declared emergencies. Currently, there are a reported 7,500 cases of Monkeypox in the U.S and more are being detected daily. AIDS Healthcare Foundation will join the fight to vaccinate high-risk communities at the Monkeypox Summit this fall at the University of Miami. There, Medical professionals will shed light on exposure, early detection, and post-infection.[0:48] - Helping Solve Housing Crisis in CaliforniaAHF doing our partThe housing crisis in California is one of the most visible and persistent obstacles for social wellbeing. There are failed systems, finger pointing, and a clear lack of accountability. That is about to change. Adaptive reuse is a practice that involves economically repurposing an older, depleted, or otherwise vacant building for the purpose of offering permanent and affordable housing. On Friday August 5th, AHF and Housing is a Human Right held a preview at the Barclay Hotel of their new exhibit, “Adaptive Reuse: Transforming Buildings, Transforming Lives. City officials were invited to tour the space and learn about AHF's housing efforts. AHF and Housing is a Human Right were presented a Certificate of Recognition from the state of California.[1:36] - The 24th International AIDS ConferenceSpreading the news about our “condom emoji” campaignThe 24th International AIDS Conference kicked off in Montreal, Canada on July 29th. AHF hosted an interactive satellite event to discuss advocacy initiatives. At the conference, AHF shared their innovative “Condom Emoji” campaign with public health leaders across the globe. AHF offered pins of eggplant emojis with condoms on them for global leaders to wear at the conference. The condom emoji pins and campaign are used to promote safe sex through safe sexting. To join in on the campaign, sign the petition at: condomemoji.org.[2:09] - AHF Now Offering COVID-19 AntiviralAsk an AHF pharmacist for informationDid you know AHF pharmacy offers Paxlovid, Pfizer's COVID-19 antiviral pill. Studies show that Paxlovid reduces the risk of hospitalization or death by 89 percent in high-risk patients who experienced symptoms for three days or less. The antiviral was granted an emergency use authorization by the Food and Drug Administration for anyone ages 12 and older who weighs at least 88 pounds, and is at high risk for severe disease. Paxlovid should be taken within the first five days of experiencing symptoms. If taken after this 5-day window, the damage done to the body by COVID-19 can't be undone by the antiviral. All AHF pharmacists will have more information on eligibility and use of Paxlovid.[2:55] - AIDS Walk Atlanta Music Festival & 5K RunDon't miss out on Sept. 24thThe AIDS Walk Atlanta music festival and 5K run is almost here. The fundraiser is a great way to give back to the Atlanta community for those living with HIV and AIDS. This year it is being headlined by Wale and Trina. AIDS Walk Atlanta attendees will also enjoy food trucks, games, prizes, and of course, AIDS Walk Atlanta swag. If you've registered for the walk, remember to bring a face covering, sunblock, sunglasses, your ID, and comfy shoes. If you haven't registered, visit aidswalkatlanta.org right now. We walk September 24th.RESOURCES:[0:10] - Monkeypox Outbreak Info[0:48] - Helping Solve Housing Crisis in California[1:36] - The 24th International AIDS Conference[2:09] - About Paxlovid[2:55] - AIDS Walk Atlanta Music Festival & 5K RunABOUT AFTER HOURS:The AIDS Healthcare Foundation is the world's largest HIV/AIDS service organization, operating in 45 countries globally. The mission? Providing cutting-edge medicine and advocacy for everyone, regardless of ability to pay.The Inside Scoop podcast is your on-the-go listen for top news and current initiates at AHF in five minutes or less.Learn more at: https://www.aidshealth.orgABOUT DETROIT PODCAST STUDIOS:In Detroit, history was made when Barry Gordy opened Motown Records back in 1960. More than just discovering great talent, Gordy built a systematic approach to launching superstars. His rigorous processes, technology, and development methods were the secret sauce behind legendary acts such as The Supremes, Stevie Wonder, Marvin Gaye, Diana Ross and Michael Jackson.As a nod to the past, Detroit Podcast Studios leverages modern versions of Motown's processes to launch today's most compelling podcasts. What Motown was to musical artists, Detroit Podcast Studios is to podcast artists today. With over 75 combined years of experience in content development, audio production, music scoring, storytelling, and digital marketing, Detroit Podcast Studios provides full-service development, training, and production capabilities to take podcasts from messy ideas to finely tuned hits. Here's to making (podcast) history together.Learn more at: DetroitPodcastStudios.com

In this podcast, Jessica Rodrigues, with AVAC: Global Advocacy for HIV Prevention, provides a description of a Dual Prevention Pill and why it can be used as a case study for future multipurpose technologies (MPTs). She presented these topics at the International AIDS Conference 2022 during a session titled "Demand, delivery, and data for decision-making: How market preparation for the Dual Prevention Pill is reimagining prevention programs for a future with MPTs"

In this podcast, Jessica Rodrigues, with AVAC: Global Advocacy for HIV Prevention, speaks about ways communities can overcome barriers to the access of pre-exposure prophylaxis (PrEP), including ambitious targets, funding, early adoption, and simplified delivery beyond a health facility. She presented this topic at the International AIDS Conference 2022 during a session titled "PrEP-ing for 2030: Why optimization and scale-up of the PrEP service and product mix is critical to addressing unmet PrEP need and supporting effective use towards 2030 HIV prevention goals."

In this crossover episode with Pandemic Planet, recorded during the International AIDS Conference in Montreal, Katherine Bliss speaks with Eamonn Murphy, Deputy Executive Director of Programmes at UNAIDS, the Joint UN Program on HIV and AIDS, about the agency's latest report, “In Danger.” Sounding the alarm regarding faltering progress in HIV prevention and treatment over the course of the pandemic, the report calls for greater attention to implementing legal protections for vulnerable populations and highlights the particular challenges girls and young women have faced in preventing infections and accessing testing and treatment. Katherine and Eamonn also discuss the lessons that can be learned from countries that have managed to make progress despite pandemic-related challenges, and what opportunities the greater uptake of self-testing and use of digital communications technologies during the pandemic may mean for HIV services. Eamonn Murphy, Deputy Executive Director of Programmes, leads UNAIDS' efforts in promoting an expanded and integrated United Nations system response to HIV at the country, regional, and global levels. Previously he was Regional Director for Asia and the Pacific, where he supported countries across the region in achieving the goals outlined in the United Nations Political Declaration on Ending AIDS as well as the Global AIDS Strategy.

In this crossover episode with AIDS Existential Moment, recorded during the International AIDS Conference in Montreal, Katherine Bliss speaks with Eamonn Murphy, Deputy Executive Director of Programmes at UNAIDS, the Joint UN Program on HIV and AIDS, about the agency's latest report, “In Danger.” Sounding the alarm regarding faltering progress in HIV prevention and treatment over the course of the pandemic, the report calls for greater attention to implementing legal protections for vulnerable populations and highlights the particular challenges girls and young women have faced in preventing infections and accessing testing and treatment. Katherine and Eamonn also discuss the lessons that can be learned from countries that have managed to make progress despite pandemic-related challenges, and what opportunities the greater uptake of self-testing and use of digital communications technologies during the pandemic may mean for HIV services. Eamonn Murphy, Deputy Executive Director of Programmes, leads UNAIDS' efforts in promoting an expanded and integrated United Nations system response to HIV at the country, regional, and global levels. Previously he was Regional Director for Asia and the Pacific, where he supported countries across the region in achieving the goals outlined in the United Nations Political Declaration on Ending AIDS as well as the Global AIDS Strategy.

Welcome to the Instant Trivia podcast episode 555, where we ask the best trivia on the Internet. Round 1. Category: Flower Power 1: You can get a low-cal treat by sniffing Cosmos astrosanguineus, with the aroma of this sweet treat. Chocolate. 2: This popular Christmas flower comes in several different colors, but the red variety is in greatest demand. the poinsettia. 3: This "bruised" Maryland state flower is also called a yellow daisy. Black-Eyed Susan. 4: A species of this beautiful tropical flower is classified as vanilla planifolia. the orchid. 5: The term "perfect" refers to a flower that has both of these male and female reproductive organs. Stamens and pistils. Welcome to the Instant Trivia podcast episode 555, where we ask the best trivia on the Internet. Round 1. Category: The Jackie Auction 1: Can we talk? This comedienne snapped up a French painting, saying it was for her daughter Melissa. Joan Rivers. 2: A triple strand of these went for $211,500, even though they were fake. pearls. 3: Lyricist Carole Bayer Sager paid $453,500 for this piece of furniture JFK used in the White House. a rocking chair. 4: This husband of JFK's niece "terminated" the bidding for a set of Kennedy's golf clubs with $772,500. Arnold Schwarzenegger. 5: The decorator who bought this item for $48,875 said the first thing he measured with it was his sanity. a tape measure. Round 2. Category: In The News 2005 1: This country's new president Ahmadinejad may have minored in embassy hostage taking in the 1970s. Iran. 2: 12 years after approving NAFTA, Congress barely passed this trade deal opening southern markets. CAFTA. 3: On Sept. 28, 2005 he stepped down as House Majority Leader (at least temporarily) upon being indicted. Tom DeLay. 4: Napster's gone legit, but the Supreme Court ruled against this file-sharing company in MGM Studios v. it. Grokster. 5: (Hi, I'm Nancy Grace with CNN Headline News.) On a busy March 16, 2005, I reported on Scott Peterson's death sentence and this actor's murder acquittal. Robert Blake. Round 3. Category: Africana 1: The southern part of Africa is often called "Sub-" this 3 1/2-million-square-mile area. Sahara. 2: The country's name is properly pronounced "Luh-Soo-Too", but is spelled this way. L-E-S-O-T-H-O. 3: In 2000 Durban in this country hosted the 13th International AIDS Conference and the first held on the continent. South Africa. 4: A lion subspecies shares its name with these nomadic people of Tanzania and Kenya. Masai. 5: Meaning "guided one", it was the title of the 1880s Sudanese leader whose forces defeated General Gordon. The Mahdi. Round 4. Category: The Rise Of The Machines 1: This refrigerator introduced in 1918 was named for a scientist who created a temperature scale. Kelvinator. 2: Milestone machines using this type of energy include Clarence Kemp's 1891 water heater. solar energy. 3: The 880-ton Hulett ore unloaders were built for ports like Cleveland and Ashtabula along this lake. Lake Erie. 4: Barthelemy Thimmonier, an early maker of these machines, saw them smashed by a mob of angry tailors. sewing machines. 5: In computers, the ILLIAC IV pioneered the simultaneous processing of many operations, known by this geometric term. parallel processing. Round 5. Category: Washingtonians 1: Since his death in 1970, some 100 albums of this guitarist's wo

Cal brings us the latest from the International AIDS Conference 2022. In this episode, he speaks with people involved with PLHIV communities across the world, as well as evolving public health responses. Guests: John Oliver Corciega from LoveYourself Inc. in the Phillipines Robbie Lawlor from the Poz Vibe Podcast in Ireland Mother Elle Barbara, Host of AIDS 2022 Vogue Ball & Intervention/Community Worker Dr Nomathemba Chandiwana from the University of Ezintsha Check out our other JOY Podcasts for more on HIV, COVID-19 and queer health & wellbeing. If there's something you'd like us to explore on the show, send through ideas or questions at wellwellwell@joy.org.au

O International AIDS Conference, o AIDS 2022, ocorreu entre os dias 29/07 a 02/08 em Montreal, no Canadá e a infectologista e editora do Portal PEBMED, Isabel Mendes, trouxe os principais destaques do congresso como. Saiba mais sobre: atualizações dos guidelines da OMS em relação a PrEP e ao tratamento de meningite criptocócica, dados em relação ao HIV e à gravidade de Covid-19 além de detalhes sobre o caso que está sendo considerado o quarto caso de cura de HIV, de um paciente conhecido como “City of Hope”. Aperte o Play e confira!

Jack and Cal discuss what the International AIDS Conference is, what previous conferences have focused on, and what's new this year. Cal was at AIDS 2022 in Montreal, and he talks about the significant focus that Monkeypox had at the event. We also hear from AFAO's Acting CEO Heath Paynter and Thorne Harbour Health's CEO Simon Ruth on Australia's response to Monkeypox. Since this episode was recorded, 450,000 doses of the third-generation Jynneos (AKA Imvamune or Imvanex) Monkeypox Vaccine have been procured by the Federal Government. Federal Health Minister Mark Butler's media release says the first delivery of roughly 22,000 doses will arrive in the country later this week. Check out our other JOY Podcasts for more on HIV, COVID-19 and queer health & wellbeing. If there's something you'd like us to explore on the show, send through ideas or questions at wellwellwell@joy.org.au

The UN response to HIV/AIDS is under threat from a host of international crises, from COVID to the war in Ukraine, and the ensuing financial challenges faced by  countries across the world. Mandeep Dhaliwal is the director of HIV and health at the UN Development Programme (UNDP). She spoke to Conor Lennon from UN News ahead of the 2022 International AIDS Conference. She warned that the UN, and other organizations, are losing ground in the fight against the disease.

The UN response to HIV/AIDS is under threat from a host of international crises, from COVID to the war in Ukraine, and the ensuing financial challenges faced by  countries across the world. Mandeep Dhaliwal is the director of HIV and health at the UN Development Programme (UNDP). She spoke to Conor Lennon from UN News ahead of the 2022 International AIDS Conference. She warned that the UN, and other organizations, are losing ground in the fight against the disease.

This podcast features Kaleshwar, a BCom student and mentor with Snehagram in Karnataka speaks not only about seemingly insurmountable challenges but also with the steely resolve and rocky grit with which he overcame them, and continues to do so. He is in conversation with CNS Executive Director Shobha Shukla who spoke to him around AIDS 2022 (24th International AIDS Conference) in Montreal, Canada. Listen to this podcast on Apple Podcasts, Amazon Music, Google Podcasts, Spotify, Stitcher, TuneIn, aCast, Podtail, BluBrry, Himalaya, ListenNotes, American Podcasts, CastBox FM, Ivy FM, and other podcast streaming platforms.

 This podcast features Doris Peltier who is among the Plenary Speakers of #AIDS2022 (24th International AIDS Conference) in Montreal, Canada. She is in conversation with CNS founder, Executive Director and Managing Editor Shobha Shukla. Doris Peltier has been dedicatedly working with the indigenous HIV movement in Canada for over twenty years. She is also the Community Engagement Coordinator with the Feast Centre for Indigenous STBBI Research, at McMaster University.Listen to this podcast on Apple Podcasts, Amazon Music, Google Podcasts, Spotify, Stitcher, TuneIn, aCast, Podtail, BluBrry, Himalaya, ListenNotes, American Podcasts, CastBox FM, Ivy FM, and other podcast streaming platforms. 

This podcast features Father Teji Thomas is the Director of Snehagram in Karnataka, India. He is in conversation with CNS Executive Director Shobha Shukla around AIDS 2022 (24th International AIDS Conference) in Montreal, Canada.Listen to this podcast on Apple Podcasts, Amazon Music, Google Podcasts, Spotify, Stitcher, TuneIn, aCast, Podtail, BluBrry, Himalaya, ListenNotes, American Podcasts, CastBox FM, Ivy FM, and other podcast streaming platforms.

This podcast features Dr Michael Babu Raj of Sneha Charitable Trust shares insights about I'M Possible Fellowship that is reimagining how we can support children living with HIV to grow up normally and live normal fulfilling lives in a society that gives them a fair chance with equity, rights, justice, and dignity. He is in conversation with CNS Executive Director Shobha Shukla around AIDS 2022 (24th International AIDS Conference) in Montreal, Canada. Dr Michael Babu Raj is the former Deputy Director of KHPT (Karnataka Health Promotion Trust). Listen to this podcast on Apple Podcasts, Amazon Music, Google Podcasts, Spotify, Stitcher, TuneIn, aCast, Podtail, BluBrry, Himalaya, ListenNotes, American Podcasts, CastBox FM, Ivy FM, and other podcast streaming platforms.

As Montréal, Québec prepares to host the 24th International AIDS Conference this July, it's important to reflect on the fifth international AIDS conference in 1989. In this Queer Legends Quickie, Concordia University professor Karen Herland takes us behind the scenes of pre-internet activism that helped changed everything.

"I love the concept of Purgatorial Hell: I think that Hell is corrective, purgative, Purgatorial, temporal, curative, and remedial, and does not last forever. I want to say that if there's a Paradise, all good people (Christians and non-Christians go there.)." -Antonio Myers "According to a new study presented at the International AIDS Conference in Australia, the transmission of HIV among sex workers could significantly be reduced by around 33-46 percent if prostitution were decriminalized. It may sound contradictory to other people's opinions, but the study looks pretty sensible. In places, where prostitution is illegal, sex workers are, in fact, more susceptible to sexually transmitted disease (STD) because of lack of access to healthcare and other social services. This is not to mention that sex workers face discrimination, stigma, and harassment, which drive them more to less likely practice safe sex. Furthermore, sex workers usually experience panicky situations, wherein they are forced to forgo wearing protection, such as the pressure from their pimps and clients, and the fear of using their condoms as evidence against them when law officials caught them. If the government of the United States and other countries will legalize the sale and purchase of sexual services, it would substantially reduce the number of cases regarding STDs and more importantly, make all sex workers healthier. Once legalized, we can require every sex worker to use condoms and be medically examined regularly for HIV and other related diseases to protect them and avoid causing of widespread health problems. This will not be hard to execute because what sex workers want is money and not disease. In Nevada, sex workers are required to get monthly blood test for HIV, syphilis, as well as weekly blood test for gonorrhea and Chlamydia trachomatis. Furthermore, the use of condom there is mandatory." --- Send in a voice message: https://anchor.fm/antonio-myers4/message Support this podcast: https://anchor.fm/antonio-myers4/support

Introducing the Black American with a flair for fashion who inspired a new kind of Gay activism in Montreal. Blane Charles had already made a name for himself in ACT UP New York by the time he attended the 1989 International AIDS Conference in Montreal. Blane stayed in the city for a few years, co-founded ACT UP MTL with queer human rights legend Michael Hendricks and co-created the World Ball For UNITY. The ‘World Ball' - like ‘Sex Garage' - helped build bridges and allies within Montreal's fractured LGBTQ2S community. This episode showcases a fierce, Black, New York queen who's spirit sparked a revolution for Quebec Queer rights.

Joel Gustave Nana Ngongang was a Pan-Africanist, leading African/Cameroonian Queer rights advocate and HIV/AIDS activist. This Opening Plenary was recorded in 2010 at the MSM Pre-Conference to the International AIDS Conference in Vienna (Austria). © International AIDS Conference of Vienna (2010) --- Send in a voice message: https://anchor.fm/working-for-our-wellbeing/message

Flexiroam, a provider of global data roaming, has shifted gears to look into other ways to serve customers with their superconnector platform. One of the opportunities is the rise in the number of virtual conferences, now that social distancing measures are in place. For the first time, the International AIDS Conference was held virtually and Flexiroam was selected to be the connector of choice by the organisers, linking 800 delegates across Africa to the online international gathering of AIDS activists and researchers. Whilst this may be a great success for the company, it came at a cost - having to let go of 80% of the staff.

Jonny dives into the challenges of reopening schools in the fall if the pandemic isn't dealt with better in this country. He also reviews what Dr. Anthony Fauci has been up to since getting the cold shoulder from the White House, including his talk at the 2020 International AIDS Conference.

Jonny dives into the challenges of reopening schools in the fall if the pandemic isn't dealt with better in this country. He also reviews what Dr. Anthony Fauci has been up to since getting the cold shoulder from the White House, including his talk at the 2020 International AIDS Conference.

Every week, The American Journal of Managed Care® recaps the top managed care news of the week. This week, the top managed care news included CMS planning to pay more for at-home dialysis equipment; ACR supports continued use of telemedicine after the COVID-19 pandemic passes; coverage of AIDS 2020, the 23rd International AIDS Conference. Read more about the stories in this podcast: CMS Seeks Incentives for At-Home Dialysis in Wake of COVID-19: https://www.ajmc.com/newsroom/cms-seeks-incentives-for-athome-dialysis-in-wake-of-covid19 ACR Position Statement Supports Use of Telemedicine After COVID-19 Crisis: https://www.ajmc.com/newsroom/acr-position-statement-supports-use-of-telemedicine-after-covid19-crisis Telehealth Growth in April Suggests Continuing Impact of COVID-19: https://www.ajmc.com/contributor/robin-gelburd-jd/2020/07/telehealth-growth-in-april-suggests-continuing-impact-of-covid19 Study Results Show Possible Link Between Medicaid Expansion, Drop in Advanced Breast Cancer: https://www.ajmc.com/newsroom/study-results-show-possible-link-between-medicaid-expansion-drop-in-advanced-breast-cancer- AIDS 2020: Virtual: https://www.ajmc.com/conferences/aids-2020 A Timeline of COVID-19 Developments in 2020: https://www.ajmc.com/focus-of-the-week/a-timeline-of-covid19-developments-in-2020 Physician and Patient Tools to Improve Chronic Kidney Disease Care: https://www.ajmc.com/journals/issue/2018/2018-vol24-n4/physician-and-patient-tools-to-improve-chronic-kidney-disease-care

MF Akynos is the founder of the Black Sex Worker Collective, author, performance artist, filmmaker and an educator in the fields of sexuality, and HIV rights. As the current director of the Black Sex Worker Collective she has convened public art actions in New York City for International Whores Day (June 2, 2018) and for International Sex Worker Rights Day in March 2018 in response to the passage of repressive Federal legislation restricting online speech, she has represented US sex workers at the International AIDS Conference in Amsterdam, and has raised funds for marginalized sex workers directly impacted by the current political climate in the United States. She has advised other non-profit organizations including Desiree Alliance, where she has spearheaded the arts track for the national conference, and the Best Practices Policy Project, where she works on UN Policy relating to women at the Commission on the Status of Women and during the Universal Periodic Review of the human rights record of the United States at the Human Rights Council. She is also the founder of the production company “Little women, BIG HAIR” through which she has developed and presented numerous creative works addressing the intersections of Blackness and sexuality including Darkie: Black Aesthetics (a multi-media variety show), THICK (a variety zaftig revue), Dark, Nude Storytellers (spoken word review) and Koffee (a burlesque troupe). Akynos has performed at the NYC Burlesque Festival, the Berlin Burlesque Festival and in many other venues. She obtained her undergraduate degree from Goddard College and is currently pursuing a Masters in Fine Art (MFA) in performance at the same institution. She has published her work at A Kiss For Gabriela and has a co-authored peer reviewed publication in The Handbook of Sex Work Research (Routledge, 2018). Payment links: thebswc.org/donate-1 Cashapp: $bswc OR patreon.com/akynos Social media handles: IG/FB: thebswc Twitter: theblackswc ----- DiDi Delgado is creating change (unapologetically). http://linktr.ee/thedididelgado https://thedididelgado.com/ --- Support this podcast: https://anchor.fm/the-full-set-podcast/support

More “Queering the Beeb”; two U.S. queer icons and a hero fall to COVID-19, the 2020 International AIDS Conference goes virtual for safety, 17 Senators and GLAAD push the U.S. Food & Drug Administration to allow blood donations by gay and bisexual men, U.K. LGBTQ help line calls surge with isolation concerns, COVID-19-forced border closures separate rainbow families, Trump’s Justice Department backs a ban on trans girl athletes, and more global LGBTQ news!

Presenter Isy Suttie talks to the inspiring Mercy Shibemba who decided to start challenging stigmas around HIV after she found out that she was born with the virus. It’s a journey that has taken her across the world, resulting in her receiving a Diana Award and much more. When Mercy was told by her Doctor that she was born with HIV, she was confused about the virus she didn’t then know much about. After meeting other young people with HIV at an event in London, she started working with the Children’s HIV Association to challenge stigmas attached to the virus and show that when treated properly HIV doesn’t stop anyone from living a normal life. After meeting Prince Harry at the International AIDS Conference in 2016, she came out publicly as HIV positive a year later when he presented her with a Diana Award. Since then Mercy has continued to campaign on HIV Awareness and she’s now involved in a commission aiming to end HIV transmissions in England by 2030. This is how Mercy is changing the world…

TRANSGENDER TURMOIL 11/5/19 i am #UnapologeticallyJosh and THIS is #TheUprising on www.str8indieradio.com! Understanding and accepting the topics around transgender individuals can be more than difficult to process. This discussion has become all the more pressing with controversy involving gender reassignment and hormone therapy, the use of public bathrooms, and even participation in athletics. Join me on TUESDAY, NOVEMBER 5th at 10pm (EST), as i explore this provocative and often polarizing social issues. My Guest is Kiara St. James, who is joining us by phone from NYC. Kiara St. James, Is a community organizer and public speaker. She has been instrumental in changing shelter policies that were discriminatory towards the Trans community, and presented workshops concerning marginalized communities at the International AIDS Conference in Vienna, Austria and the United Nations, as well as at other conferences and academic institutions. For the last 17 years Kiara has also been coordinating meetings with legislators to discuss the importance of passing Gender Expression Non Discrimination Act, a bill that will enrich the lives of all New Yorkers through creating culturally affirming spaces. and was finally Legislated into Law January 15 2019 . Kiara is the Founder and current Executive director of the New York Transgender Advocacy Group (NYTAG inc), A grassroots 501c-3 non-profit organization, that is Trans-led and intent on creating new opportunities for the Trans community, through various partnerships and sustainable innovative initiatives. Kiara believes that the fight now should be about Equity and shifting of resources to better address income disparities. NOW BOOKING GUESTS and SPONSORS... Respond below, inbox me, or email maskingandko2013@gmail.com.  

In this episode, Andrew Schwartz interviews Congresswoman Barbara Lee. She represents California's 13th district, which includes the city of Oakland, and is the co-founder and co-chair of the bipartisan Congressional HIV/AIDS Caucus. Rep. Lee tells Andrew how critically important it is that the International AIDS Conference is returning to the Bay Area after 30 years.

In this episode, Andrew Schwartz interviews Congresswoman Barbara Lee. She represents California’s 13th district, which includes the city of Oakland, and is the co-founder and co-chair of the bipartisan Congressional HIV/AIDS Caucus. Rep. Lee tells Andrew how critically important it is that the International AIDS Conference is returning to the Bay Area after 30 years.

Geetu Hinduja is from Mumbai, India. She is a folk singer and guitarist in various genres - alternative, soft rock, pop, indie. Geetu tells vivid stories that transport the listener to the landscape of her mind. Her music is music for the soul. Training included Indian classical music under Neela Bhagwat, bhajans under P.D. Jalota, and with jazz vocalist and composer Mili Bermejo. She sang with the Mumbai choir Stop Gaps. Her music reflects her hopes and dreams, the struggle to belong, and her identity as a woman in Indian society. From Rumi’s poetry to reflections of Mumbai’s street life, from Adi Shankaracharya’s contemplation of the self to the hypocrisy of modern life – all find expression in her powerful voice and memorable melodies. Dancing Free was released in 1993 and, 19 years later, she released her Hope Faith Time & Me (2012), showcasing her musical and philosophical evolution. That album was dedicated to her sister Jyoti, who died fighting breast cancer in 2010. Geetu has toured, since 2009, performing originals and covers of Joan Baez, Natalie Merchant, Dido, Suzanne Vega, Bob Dylan, Alanis Morissette, and Bonnie Raitt. She performed at Kala Ghoda Festival in Mumbai, Jadhavgadh Music Festival, 18 Degrees Festival, Shillong, live for Anita Dongre (LFW, 2014), Celebrate Bandra Festival, and the International Aids Conference, Blue Frog in Mumbai, TLR Café in Delhi, Max Mueller Bhavan for Pune Jazz Club, NGMA, and the Jaipur Literature Festival 2014. http://www.geetu.in http://wijsf.org  

Last month, top policymakers, scientists, and activists gathered in Amsterdam for the 22nd International AIDS Conference to examine the current state of global HIV/AIDS response, and how that response should be shaped by the global health community in the years to come. In this episode of Take as Directed, we are joined by Owen Ryan, Executive Director of the International AIDS Society (IAS), which organizes the International AIDS Conference every two years. Owen discusses the main science and policy takeaways from this year’s conference and addresses the concerns raised by activists about holding the conference in the United States in 2020, which is set to take place in San Francisco and Oakland.

 AIDS 2018 - Part II The International AIDS Conference occurs every two years somewhere around the globe. This year AIDS 2018 is held in Amsterdam. Many people may recall Melbourne hosting the event just four years ago – AIDS 2014. Our latest episode marks the closing of AIDS 2018 in Amsterdam, and Michael and Cal wrap up on some highlights from the conference. The conference offers an opportunity for the international HIV and AIDS community to gather to find out the latest developments in the global response to the epidemic. Well, Well, Well's Cal was at the conference to adsorb the community mobilisation, and key findings from research which informs the way we look at and respond to the changing landscape of HIV in Australia and abroad. With the help of Michael back in the JOY 94.9 studios we were able to unpack just some of the highlights from the course of AIDS 2018 including: Three distinct stories highlighting Indigenous voices from across the globe Peter Waples-Crowe from Thorne Harbour Health speaks to the lack of Australian indigenous representation on a global scale, and what we can learn from other indigenous communities in our own work in health promotion Paula Simonsen, a Sami woman from Northern Norway speaks to the state of HIV, stigma, and barriers to testing and treatment for HIV in northern Europe for first nations peoples. Trevor Stratton, A Coordinator for International Indigenous Working Group on HIV and AIDS, speaks about three distinct local indigenous peoples in Canada - and the film Strong Medicine which targets those populations in an authentic way. Pron4PrEP, an innovative way to contexualise the use of PrEP, and U=U in an adult film setting using stark and explicit imagery juxtaposed with talking heads validating and confirming the stories told through an (often explicit) pronographic setting. Cal talks with Jason Domino from The Porn4PrEP website which contains explicit and non-explicit versions of the video mentioned in this podcast. How social networking app Hornet is responding to global LGBTI criminalisation through their campaign #DecriminalizeLGBT. Cal talks with Alex Garner from Hornet Finally, Cal touches base with George Ayala from M-PACT (formerly MSMGF) about the potential barriers to AIDS2020 being held in San Francisco & Oakland, California. What does that mean for those unable to travel to the U.S.A under restrictive travel bans, and how does that mirror what has happened at the International AIDS Conference in histroy?   This show, Episode #630 originally aired Thursday 2nd August, 2018. Grab this and other podcasts from the Well, Well, Well team on iTunes | Spotify | or your favourite podcast platform - or head to joy.org.au/wellwellwell Head to www.thorneharbour.org for more information about Thorne Harbour's LGBTI health and well-being services Thorne Harbour is social! facebook: facebook.com/thorneharbour  |  twitter: @ThorneHarbour  |  instagram: @thorneharbour Check out Part I of the series

More people are going to die of AIDS-related deaths globally, due to insufficient funding from donors. This is a warning issued at the 22nd International AIDS Conference in Amsterdam, Netherlands. Intenational advocacy organisation, Health Gap, says while HIV prevention and treatment tools have been proven to work, millions of people will continue to die unnecessarily. Thabile Mbhele reports

Antoine Craigwell joins our host Kristin Walker again to discuss his upcoming event: In My Mind: A LGBTQI+ people of color mental health conference and Mental Health and HIV.As a journalist, Antoine Craigwell wrote for Out In Jersey magazine, The Bilerico Project, FORTUNE Small Business magazine, The Bronx Times Reporter, The New York Amsterdam News, was the assistant editor with The Network Journal, and a contributor to mainstreet.com. He graduated from Bernard Baruch College of the City University of New York, and in 2008 he earned awards from the New York Association of Black Journalists for a public policy series about NYC’s Riker’s Island, and on healthcare in NYC. He produced the documentary “You Are Not Alone” in which Black gay men speak about their struggles with depression and facilitates discussion forums on depression and HIV in Black gay men. he presented a poster exhibition “Examining Depression and HIV in Black gay men” at the 2012 International AIDS Conference in Washington, DC. Antoine founded and is president and CEO of DBGM, Inc.a non-profit organization committed to raising awareness of the underlying factors contributing to depression in Black gay men, to prevent their suicides. The organization has hosted several community discussion forums on depression affecting Black gay men nationwide.www.dbgm.org

On Start the Week Tom Sutcliffe looks at what happens during a health epidemic and its aftermath. The US activist Peter Staley was instrumental in forcing scientists and pharmaceutical companies to develop life-saving HIV/AIDs drugs. Thirty years later and with drugs now readily available, the concern is that the rate of new cases of HIV remains constant. Professor Anne Johnson was involved in the biggest-ever-official investigation of Britain's sexual habits, which was vetoed at the time by Margaret Thatcher. She says continuing to understand people's attitudes and behaviour is vital to the nation's health. More than eleven thousand people died during the Ebola outbreak in West Africa. When the crisis hit its peak in 2014 there were no effective drugs and Professor Peter Horby was one of a team of scientists who conducted a drugs trial in the midst of the epidemic. He explains how what they discovered can be used for future health scares. The author Louise Welsh is completing a trilogy of novels in which a killer disease has devastated the world. She explains why plague literature has proved so popular and enduring. Producer: Katy Hickman Photo: ACT UP activists at the International AIDS Conference in San Francisco, 1990 Credit: Rick Gerharter.

Benjamin is back from the International AIDS Conference in South Africa, and talking with Simon about the experience leads to a discussion of misogyny, masculinity, and what HIV can tell us about the politics of gay-male sex and experience. See acast.com/privacy for privacy and opt-out information.

At the International AIDS Conference in Durban, South Africa, Benjamin interviewed Cianán Russell, a trans man who ran the only session in the conference program focused on transmasculine folk. Starting from a discussion of how the session came together, Cianán touches on misogyny among gay men, the complications of identity politics, male sexual entitlement, the need for men to explore vulnerability, and more.CONTENT WARNING: This episode contains discussions of sexual assault. Sections of the interview were published in Star Observer: http://www.starobserver.com.au/news/aids-conference-2016-trans-men-navigating-the-politics-of-misogyny-in-gay-spaces/151122 See acast.com/privacy for privacy and opt-out information.

Kate Adie introduces analysis, reflection and reporting from correspondents around the world. As Turkey recovers from last week's attempted coup, Mark Urban finds that in Ankara the conspiracy theories are burgeoning. Could these events be the pretext (or a catalyst) for Turkey snubbing the EU, walking away from its relationship with the US or even distancing itself from Nato? Karen Allen's been at the 21st International Aids Conference in Durban to get a global picture of the HIV epidemic; while there have been some notable advances on treatment and prevention, she sees South Africa's still struggling to deal with the virus. Despite the heavily-reported warming up of its relationship with the USA, Cuba still has a hidebound economy and is warning its people to tighten their belts and prepare for austerity - again - says Will Grant in Havana. Martin Patience reaches some resentful corners of Nigeria's Delta region the only way anyone can: by speedboat, and with an entourage of local dignitaries. And Antonia Quirke treads in the footsteps of giants, seeing how the beautiful, creamy marble which once inspired Michelangelo is still being quarried from a site in Tuscany.

Hopes of an imminent cure for HIV/Aids are diminishing following statements by leading researchers at the International Aids Conference in Durban. Some scientists at the conference say there has been progress regarding treatment and if used properly it can dramatically increase life expectancy. We caught up with general secretary of the Treatment Action Campaign, Anele Yawa for more deails

The Sex Workers Education and Advocacy Taskforce has again called for the decriminalisation of sex work. Various organisations including SWEAT and the Women's Legal Centre met in Cape Town on Wednesday to discuss problems in the sex industry ahead of the 21st International Aids Conference in Durban next week. Chris Mabuya reports....

Jade Harrell with Imani Aisha, Williams and Associates and Joan Ferguson, community advocate and trainer. St. Louis leads the state of Missouri in doctor's diagnosing people with HIV/AIDS. In St Louis, Missouri 2014, 63 percent of new HIV diagnoses were among African American women. These disease are preventable. Joan and Imani are providing awareness and prevention training all over the region and are traveling from STL to Durban, South Africa for the 21st International AIDS Conference this coming July.

Jade Harrell with Imani Aisha, Williams and Associates and Joan Ferguson, community advocate and trainer. St. Louis leads the state of Missouri in doctor's diagnosing people with HIV/AIDS. In St Louis, Missouri 2014, 63 percent of new HIV diagnoses were among African American women. These disease are preventable. Joan and Imani are providing awareness and prevention training all over the region and are traveling from STL to Durban, South Africa for the 21st International AIDS Conference this coming July.

完整文稿请关注周六微信，或登录以下网址： http://english.cri.cn/7146/2014/07/25/2582s837636.htm This is NEWS Plus Special English. I'm Mark Griffiths in Beijing. Here is the news. An international AIDS conference has been held in Australia with tribute to several delegates who were killed en route to the gathering when their plane was shot down over Ukraine. Officials at the opening ceremony for the 20th International AIDS Conference in Melbourne held a moment of silence for the six AIDS researchers and activists killed aboard Malaysia Airlines Flight 17. All 298 people on board the plane died when it was shot down by a surface-to-air missile on July 17th as it flew over rebel-held eastern Ukraine. Among the passengers was prominent Dutch researcher Joep Lange, former president of the International AIDS Society, and spokesman Glenn Thomas of the World Health Organization based in Geneva. Around 12,000 scientists and activists from 200 countries attended the conference to discuss the latest developments in HIV and AIDS research. This is NEWS Plus Special English. A new government study shows the rate of HIV infections diagnosed in the United States each year fell by one-third over the past decade. Experts hailed it as hopeful news that the AIDS epidemic may be slowing in the U.S. Researchers say that the reasons for the drop are not clear. It might mean fewer new infections are occurring, or that most infected people already have been diagnosed so more testing won't necessarily find many more cases. The study result was released ahead of the International AIDS Conference which was held between July 20th and 25th in Melbourne, Australia. HIV is the virus that causes AIDS, which destroys the immune system. The World Health Organization estimates that 35 million people globally have the virus. In the United States, 1 million people are thought to be infected, though many don't know it. You are listening to NEWS Plus Special English. I'm Mark Griffiths in Beijing. Now is the time to get moonstruck. Forty-five years ago on Sunday, Apollo 11's Neil Armstrong and Buzz Aldrin became the first humans to set foot on the moon. Armstrong's "one small step for man and one giant leap for mankind" on the dusty lunar surface on July 20th, 1969, still stirs hearts. At the launch site at Florida's Kennedy Space Center, NASA honored Armstrong on Monday with a renaming ceremony of the historic Operations and Checkout Building. Both Aldrin and Michael Collins, the Apollo 11 command module pilot who orbited the moon, were there. People can join the celebration, at the very least, by walking out and looking at the moon over the weekend. The Armstrong family had said following his death in 2012 that those who wish to honor Neil can simply honor his example of service, accomplishment and modesty; and the next time we walk outside on a clear night and see the moon smiling down at us, we can think of Neil Armstrong and give him a wink. This is NEWS Plus Special English. China's first lunar rover, Yutu, or Jade Rabbit, is still functioning despite the malfunction of some of its equipment. According to Wu Wei-ren, chief designer of China's lunar probe project, Yutu has been woken up after the past dormant period, but the problems still exist. The rover will embrace another "working day", which is about 14 Earth days, in an abnormal state caused by mechanical failures. During the lunar night, there is no sunlight to provide power to Yutu's solar panel, and the extremely low temperatures can damage its delicate electronics, so the rover must "hibernate". The 140-kilogram, six-wheeled Yutu, is part of the Chang'e-3 lunar probe. It has outlived its designed lifespan of three months since it reached the moon in mid-December last year. The rover has completed its designated scientific and engineering tasks, analyzed major elements on the lunar surface and studied mineral resources. However, after almost six weeks of operation, the moon buggy reported a mechanical control problem in January, before entering its second period of dormancy. Since then, it has been unable to move any farther, remaining around 20 meters southwest of where it landed. Its antenna and solar panels cannot be folded, either. Chinese engineers blamed the problem on the "complicated lunar surface environment". You are listening to NEWS Plus Special English. I'm Mark Griffiths in Beijing. A 38-year-old man has died of plague in northwest China's Gansu Province. The case was reported in Jiuquan City, and the man died on July 16th. He had been in contact with a dead marmot, which is a member of the squirrel family. A total of 150 people who had close contact with him, have been put in quarantine and are under medical observation. None of them has reported any symptoms of the disease so far. China's National Health and Family Planning Commission has sent disease prevention and control specialists to the city to prevent the plague from spreading. Plague is categorized as a Class A infectious disease, the most serious category under China's Law on the Prevention and Treatment of Infectious Diseases.

Iraqi Christians face ultimatum: leave or die, Another attempt in the Senate to redefine marriage & International AIDS Conference wraps up in Melbourne. The post 5 Headlines You May Have Missed (25 July) appeared first on Cradio.

In the fight between humanity and the AIDS virus, humanity is winning. That is the top line conclusion you can draw from the newest global data about HIV/AIDS from the United Nations. Erin Hofhelder of the ONE Campaign is on the line to discuss this report, preview the big International AIDS Conference in Australia, and explain why new laws against LGBT communities in some African countries may undermine the progress we've made against HIV/AIDS.  Have a listen!   

Later this month sees the 17th International AIDS Conference in Vienna. One of the topics that will be discussed there is harm reduction, and the political will to embrace it.In this podcast, we look at the effects of long term opiate substitution programmes in Muirhouse, Edinburgh. Local GP Roy Robertson discusses the research he conducted there. We also travel to Kiev in Ukraine, where Richard Hurley talks to NGOs and injecting drug users about local harm reduction programmes.

This week’s podcast focuses on the Law Enforcement Assisted Diversion Program http://leadkingcounty.org/ which “is a pre-booking diversion pilot program … to address low-level drug and prostitution crimes in the Belltown neighborhood in Seattle and the Skyway area of unincorporated King County.” A presentation from Seattle Police Department’s (Deputy) Police Chief Pugel from the International AIDS Conference (courtesy of our friends at the HCLU http://drogriporter.hu/en/hclu_tv ) and an interview with Kris Nyrop of the Defender Association. He originally spoke on this in December 2010. http://harmreduction.org/publication-type/podcast/twelve/ )

On Sunday October 14th at 9pm EST we will be speaking with Rebecca Denison  the Founder of WORLD (Women Organized to Respond to Life-threatening Diseeases). Rebecca is an Oakland-based information, support and advocacy network for HIV-positive women and their loved ones. In 1990, a month before she was scheduled to begin law school, Rebecca was diagnosed with HIV. In 1991, with support from her husband Daniel, Rebecca started the WORLD newsletter in her living room with a mailing list of 200. Six months later WORLD held their first retreat for HIV+ women, and a year later Rebecca helped start the International Community of Women Living with HIV/AIDS.  In 1995, Rebecca and Daniel decided to become parents, and in March 1996 their twin girls, Sophia and Sarah were born, both HIV-free. . Her children are now 16 years old and thriving, having recently attended the International AIDS Conference in Washington DC, while she stayed home to work in Oakland. Her husband remains HIV-negative. She has been living with HIV for 29 years.

June 2011 marked the 30th anniversary of the AIDS pandemic. Since that time, there have been over 30 million deaths from AIDS-related causes, including 1,700,000 in 2011 alone. Currently, there are approximately 34 million people living with HIV/AIDS. Despite these staggering numbers, there was great optimism at the 19th International AIDS Conference, Turning the Tide on Together, which ran in Washington, DC this past July that an AIDS free generation is within our reach. Certainly we have both the knowledge and the technology to end the pandemic, but when looking at the incidence rates, the prospect seems daunting and unattainable, and certainly not immediate. The speaker will discuss some of the highlights from the many sessions at the AIDS Conference and reveal some of the work that needs to be done to achieve an AIDS free generation and bring about the end of AIDS. Speaker: Charleen Davidson Charleen is the Executive Director at the Lethbridge HIV Connection, a position she has held since the winter of 2008. Prior to joining the Connection, Charleen worked in British Columbia's prison system, first as a Community Liaison Worker at the former Burnaby Correctional Centre for Women and later with victims of domestic violence through the Vancouver Pretrial Services Centre. It was her desire to make a difference in the community that led Charleen to the Connection upon her relocation to Lethbridge in 2008. While Charleen has attended several provincial and national AIDS conferences, AIDS 2012 was her first time participating at the international level. She always welcomes opportunities to learn more about the AIDS movement, and especially appreciates occasions for sharing new knowledge and ideas. Outside the agency, Charleen has been teaching fitness for the past 13 years, and is currently on the Board of Directors for the Galt Museum and Archives and the Board of Directors for the Alberta Community Council on HIV. Charleen holds a Bachelor of Arts Degree from the University of Lethbridge and a Masters Degree from the University of Toronto.

June 2011 marked the 30th anniversary of the AIDS pandemic. Since that time, there have been over 30 million deaths from AIDS-related causes, including 1,700,000 in 2011 alone. Currently, there are approximately 34 million people living with HIV/AIDS. Despite these staggering numbers, there was great optimism at the 19th International AIDS Conference, Turning the Tide on Together, which ran in Washington, DC this past July that an AIDS free generation is within our reach. Certainly we have both the knowledge and the technology to end the pandemic, but when looking at the incidence rates, the prospect seems daunting and unattainable, and certainly not immediate. The speaker will discuss some of the highlights from the many sessions at the AIDS Conference and reveal some of the work that needs to be done to achieve an AIDS free generation and bring about the end of AIDS. Speaker: Charleen Davidson Charleen is the Executive Director at the Lethbridge HIV Connection, a position she has held since the winter of 2008. Prior to joining the Connection, Charleen worked in British Columbia's prison system, first as a Community Liaison Worker at the former Burnaby Correctional Centre for Women and later with victims of domestic violence through the Vancouver Pretrial Services Centre. It was her desire to make a difference in the community that led Charleen to the Connection upon her relocation to Lethbridge in 2008. While Charleen has attended several provincial and national AIDS conferences, AIDS 2012 was her first time participating at the international level. She always welcomes opportunities to learn more about the AIDS movement, and especially appreciates occasions for sharing new knowledge and ideas. Outside the agency, Charleen has been teaching fitness for the past 13 years, and is currently on the Board of Directors for the Galt Museum and Archives and the Board of Directors for the Alberta Community Council on HIV. Charleen holds a Bachelor of Arts Degree from the University of Lethbridge and a Masters Degree from the University of Toronto.

June 2011 marked the 30th anniversary of the AIDS pandemic. Since that time, there have been over 30 million deaths from AIDS-related causes, including 1,700,000 in 2011 alone. Currently, there are approximately 34 million people living with HIV/AIDS. Despite these staggering numbers, there was great optimism at the 19th International AIDS Conference, Turning the Tide on Together, which ran in Washington, DC this past July that an AIDS free generation is within our reach. Certainly we have both the knowledge and the technology to end the pandemic, but when looking at the incidence rates, the prospect seems daunting and unattainable, and certainly not immediate. The speaker will discuss some of the highlights from the many sessions at the AIDS Conference and reveal some of the work that needs to be done to achieve an AIDS free generation and bring about the end of AIDS. Speaker: Charleen Davidson Charleen is the Executive Director at the Lethbridge HIV Connection, a position she has held since the winter of 2008. Prior to joining the Connection, Charleen worked in British Columbia's prison system, first as a Community Liaison Worker at the former Burnaby Correctional Centre for Women and later with victims of domestic violence through the Vancouver Pretrial Services Centre. It was her desire to make a difference in the community that led Charleen to the Connection upon her relocation to Lethbridge in 2008. While Charleen has attended several provincial and national AIDS conferences, AIDS 2012 was her first time participating at the international level. She always welcomes opportunities to learn more about the AIDS movement, and especially appreciates occasions for sharing new knowledge and ideas. Outside the agency, Charleen has been teaching fitness for the past 13 years, and is currently on the Board of Directors for the Galt Museum and Archives and the Board of Directors for the Alberta Community Council on HIV. Charleen holds a Bachelor of Arts Degree from the University of Lethbridge and a Masters Degree from the University of Toronto.

 Devarah 'Dee' Borrego is a 28-year-old, HIV+ transwoman originally from Denver, Colorado, who grew up mostly in suburban Connecticut. She acquired HIV at age 20; the same year as she began her transition. She has been living in the Boston area since 2004 where she has worked with and at a number of different community organizations in the Boston area, including JRI Health, TransCEND, the Boston Living Center and Cambridge Cares About AIDS. She's also a polyglot who speaks Spanish, French, Norwegian, American Sign Language, and a variety of other languages to various degrees. On the national scene, Dee was also a founding member of the US Positive Women’s Network (US PWN), an organization led by and for HIV+ American women to address the way HIV disproportionately affects women in the US. She currently serves as a Steering Committee member of the US PWN, as well as a member of their Strategic Communications Action Team. She's also a member of the Global Network of People Living with HIV/AIDS (GNP+) North America's Young Leaders Caucus, and the co-chair of the Economic Justice Working Group for the HIV Prevention Justice Alliance (HIV PJA). In 2010, Dee was chosen to speak at the Opening Plenary of the US Conference on AIDS (USCA) to discuss how HIV affects transgender youth. Dee attended the International AIDS Conference in Washington, DC during the summer of 2012. At the Conference, she gave presentations along with colleagues for AIDS Alliance for Youth, Families, and Children - now a part of AIDS United - geared at HIV+ youth and their providers on the topic of disclosure. Dee is passionate about the issues surrounding young, HIV+ people, especially transgender women, HIV prevention, HIV criminalization, and youth outreach and education around HIV.

This past week Robert and Jeromy attended the International AIDS Conference in Washington D.C. During tonights live show they will be sharing what it was like attending the conference and meeting people from around the world who were either living with HIV or working to end HIV. Our special guest is the amazing Aaron Laxton If you attended the IAC  we want you to call into the show at 347-215-9442 and share what your expereince was like.  

During tonight's show Robert and Jeromy will be broadcasting live from the International AIDS Conference in Washington DC. The Official Sucessor to Harry Houdini Daniel Bauer will be sitting in to share about his World Wide Debut of "Beyond Belief " that will be happening on Thursday evening as a part of AIDS 2012 Reunion and sponsored by Just Get Tested. Dr Salko will be  joining the host live to talk about Just Get Tested. JustGetTested.com is a safe place to find out what you need to know when it comes to HIV and STDs.  

During tonighs show Robert and Jeromy will be broadcasting live from the International AIDS Conference in Washington DC. Mondo Guerra  will be sittng in with the POZ I AM Radio Show hosts to dicuss his new projects and life after winning Project Runway All Stars.

POZ I AM Radio will be Broadcasting live from Washington D.C. right after the march on washington and a few hours before the opening ceromonies of the International AIDS Conference. Call in and share what you hope to get out the conference ? 347-215-9442

There have been many major developments in HIV research in the past year. So much so that many are now talking confidently about the end of the disease, zero new infections, curing HIV, etc. This interactive session will explore the developments, including those presented at the International AIDS Conference in July to which the facilitator is a delegate. There will be opportunities to explore the what is being learned and proposed and to evaluate how practical they are in various settings around the world, especially Africa where the majority of people living with the virus reside. If you have any interest in and/or experience with HIV, you will benefit from this session and your participation will benefit the rest of us.

The XVII International AIDS Conference which was held in Mexico City in early August was truly an international event with participants from every corner of the world. With over 20 000 participants, this meeting was the second largest International AIDS Conference, and the largest health-related summit ever held in the southern hemisphere.

The International AIDS conference opens today in Mexico City. One focus of the conference will be the status of the pandemic in the Americas. World Breastfeeding week raises awareness of the importance of breastfeeding for both mothers and babies; this year the focus is particularly on supporting mothers to breastfeed successfully.